Head-to-head · Cost-Efficiency Index
Framework vs Maven Clinic
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Framework
Cost-first shoppers who want doctor-guided treatment selection with a named pharmacy, if you can accept learning the price only after intake.
Visit FrameworkMaven Clinic
Cost-first shoppers who want employees whose employer or health plan already sponsors Maven -- not a fit for cash-pay compounded-GLP-1 price shopping.
Visit Maven ClinicThe verdict
Framework and Maven Clinic tie on the Cost-Efficiency Index at 45/100, so neither wins outright on the numbers. For most shoppers we'd start with Framework (ranked #463, a hair above #466) — Cost-first shoppers who want doctor-guided treatment selection with a named pharmacy, if you can accept learning the price only after intake. But Maven Clinic is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Framework.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Framework | Maven Clinic |
|---|---|---|
| Cost-Efficiency Index | 45/100 | 45/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #463 | #466 |
Framework
45/100Where the value is
- The compounding pharmacy partner is named, which most of this field does not do
- Treatment selection is doctor-guided rather than a fixed product menu
- US-licensed clinicians and a 503A pharmacy pathway
The tradeoffs
- No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
- The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
Maven Clinic
45/100Where the value is
- Large, established, reputable telehealth brand with broad clinical specialties
- Genuinely offers brand-name GLP-1 prescribing (not compounded) through a self-pay consumer track
- Metabolic and hormone health specialists plus nutrition/strength support included
The tradeoffs
- No public cash price for the self-pay GLP-1 program could be found anywhere on the site
- Core business model is employer/insurance-benefit access, not direct-to-consumer cash pay
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.